Intracranial bleeding, fibrinolysis, and anticoagulation. Causal connections and clinical implications.

This publication has 37 references indexed in Scilit:

• Activated protein C and antithrombin-III activity during arterial thrombolysis with recombinant tissue-type plasminogen activator in rabbits
  Coronary Artery Disease, 1993
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarction
  The American Journal of Cardiology, 1993
• Antithrombins as conjunctive therapy in arterial thrombolysis
  Coronary Artery Disease, 1992
• Questions unresolved by the third international study of infarct survival
  The American Journal of Cardiology, 1992
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• THROMBIN/ANTITHROMBIN-III COMPLEX LEVEL AS EARLY PREDICTOR OF REOCCLUSION AFTER SUCCESSFUL THROMBOLYSIS
  The Lancet, 1988
• A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty
  New England Journal of Medicine, 1987
• A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction
  Journal of the American College of Cardiology, 1987
• Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis
  Journal of the American College of Cardiology, 1986